ORTEXORTEX News
Live short interest, options flow, and signals — free on ORTEX.Sign up free →
Market Commentary

Accenture Hit by Wave of Analyst Cuts

By ORTEX News · Edited by , Editor, ORTEX NewsUpdated 1 min read

Produced automatically from ORTEX data and published under the ORTEX News editorial standards set by Peter Hillerberg, Editor, ORTEX News. How we publish

ShareXLinkedInReddit

ACN is taking fire from Wall Street. Four analysts slashed price targets on the IT services giant today. TD Cowen went furthest, cutting its rating to Hold from Buy. The firm's new target is $150, down from $258 — a 42% reduction. RBC Capital and Susquehanna also trimmed targets sharply, to $175 and $140 respectively.

Accenture's market cap stands at $78.3 billion. The coordinated sellside retreat suggests broad concern about AI's impact on consulting demand and slowing enterprise IT spending.

KR also drew negative analyst attention. UBS's Michael Lasser cut his target to $63 from $70, maintaining a Hold. Telsey Advisory Group's Joseph Feldman trimmed to $78 from $82, keeping a Buy. Both moves come as the grocery giant faces margin pressure and competition from discount rivals.

On the positive side, KIM earned an upgrade from Wolfe Research. Analyst Andrew Rosivach lifted the REIT to Buy from Hold with a $28 target. Strip-mall landlords are benefiting from resilient consumer traffic and tight retail vacancy rates.

CVS saw its consensus target price nudge higher to $105.38, reflecting growing confidence in the pharmacy chain's restructuring progress. Analysts now broadly rate the stock a Hold, with the target up slightly from $105.

Stocks in this article

How this article was generated

Generated
22 Jun 2026, 16:20
Prompt version
v1.0
Data sources
Analyst consensus

ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data and reviewed by the ORTEX team. Content is informational only and does not constitute investment advice.